CF PHARMTECH (02652.HK) announced its full-year results for the year ended last December, with a revenue of RMB 433 million, a year-on-year decrease of 28.8%. The net profit was RMB 2.485 million, a year-on-year decrease of 88.2%; earnings per share were 0.66 cents. No dividend was declared.
Under non-International Financial Reporting Standards, the adjusted profit last year fell by 38.8% to RMB 31.751 million

02652

CF PHARMTECH announced its full-year results for the year ended December last year, with a revenue of RMB 433 million, a year-on-year decrease of 28.8%. The net profit was RMB 2.485 million, a year-on-year decrease of 88.2%; earnings per share were 0.66 cents. No dividend was declared. Under non-International Financial Reporting Standards, the adjusted profit last year fell by 38.8% to RMB 31.751 million

"Performance" CF PHARMTECH's annual net profit is 2.485 million RMB, down 88.2%